サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1320871

世界のバイオ医薬品3PL市場：考察と予測 (2029年まで)

Global Biopharmaceutical 3PL Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 106 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のバイオ医薬品3PL市場：考察と予測 (2029年まで)
出版日: 2023年08月03日
発行: QYResearch
ページ情報: 英文 106 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、バイオ医薬品3PL (Biopharmaceutical 3PL) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のバイオ医薬品3PLの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Cold Chain
    • Non-cold Chain
  • 市場：用途別
    • 世界のバイオ医薬品3PLの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Transportation
    • Warehousing and Storage
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のバイオ医薬品3PLの市場展望 (2018-2029)
  • 世界のバイオ医薬品3PLの市場成長トレンド：地域別
    • バイオ医薬品3PL 市場規模：地域別: 2018 VS 2022 VS 2029
    • バイオ医薬品3PLの市場規模実績：地域別 (2018-2023)
    • バイオ医薬品3PLの市場規模予測：地域別 (2024-2029)
  • バイオ医薬品3PL 市場動向
    • バイオ医薬品3PL 業界動向
    • バイオ医薬品3PL 市場の促進要因
    • バイオ医薬品3PL 市場の課題
    • バイオ医薬品3PL 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 バイオ医薬品3PL ：競合別
    • 世界のバイオ医薬品3PLの収益：企業別 (2018-2023)
    • 世界のバイオ医薬品3PLの収益シェア：企業別 (2018-2023)
  • 世界のバイオ医薬品3PLの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 バイオ医薬品3PL, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界のバイオ医薬品3PL 市場集中度
    • 世界のバイオ医薬品3PL 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： バイオ医薬品3PLの収益 2022
  • 世界の主要企業 バイオ医薬品3PL 本社 および提供地域
  • 世界の主要企業 バイオ医薬品3PL, 製品およびアプリケーション
  • 世界の主要企業 バイオ医薬品3PL, 業界参入時期
  • M&A, 拡張計画

第4章 バイオ医薬品3PL 内訳データ：タイプ別

  • 世界のバイオ医薬品3PLの市場規模実績：タイプ別 (2018-2023)
  • 世界のバイオ医薬品3PLの市場規模予測：タイプ別 (2024-2029)

第5章 バイオ医薬品3PL 内訳データ：用途別

  • 世界のバイオ医薬品3PLの市場規模実績：用途別 (2018-2023)
  • 世界のバイオ医薬品3PLの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米のバイオ医薬品3PL 市場規模 (2018-2029)
  • 北米のバイオ医薬品3PL 市場規模：タイプ別
    • 北米のバイオ医薬品3PL 市場規模：タイプ別 (2018-2023)
    • 北米のバイオ医薬品3PL 市場規模：タイプ別 (2024-2029)
    • 北米のバイオ医薬品3PLの市場シェア：タイプ別 (2018-2029)
  • 北米のバイオ医薬品3PL 市場規模：用途別
    • 北米のバイオ医薬品3PL 市場規模：用途別 (2018-2023)
    • 北米のバイオ医薬品3PL 市場規模：用途別 (2024-2029)
    • 北米のバイオ医薬品3PLの市場シェア：用途別 (2018-2029)
  • 北米のバイオ医薬品3PL 市場規模：国別
    • 北米のバイオ医薬品3PL 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米のバイオ医薬品3PL 市場規模：国別 (2018-2023)
    • 北米のバイオ医薬品3PL 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のバイオ医薬品3PL 市場規模 (2018-2029)
  • 欧州のバイオ医薬品3PL 市場規模：タイプ別
    • 欧州のバイオ医薬品3PL 市場規模：タイプ別 (2018-2023)
    • 欧州のバイオ医薬品3PL 市場規模：タイプ別 (2024-2029)
    • 欧州のバイオ医薬品3PLの市場シェア：タイプ別 (2018-2029)
  • 欧州のバイオ医薬品3PL 市場規模：用途別
    • 欧州のバイオ医薬品3PL 市場規模：用途別 (2018-2023)
    • 欧州のバイオ医薬品3PL 市場規模：用途別 (2024-2029)
    • 欧州のバイオ医薬品3PLの市場シェア：用途別 (2018-2029)
  • 欧州のバイオ医薬品3PL 市場規模：国別
    • 欧州のバイオ医薬品3PL 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州のバイオ医薬品3PL 市場規模：国別 (2018-2023)
    • 欧州のバイオ医薬品3PL 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国のバイオ医薬品3PL 市場規模 (2018-2029)
  • 中国のバイオ医薬品3PL 市場規模：タイプ別
    • 中国のバイオ医薬品3PL 市場規模：タイプ別 (2018-2023)
    • 中国のバイオ医薬品3PL 市場規模：タイプ別 (2024-2029)
    • 中国のバイオ医薬品3PLの市場シェア：タイプ別 (2018-2029)
  • 中国のバイオ医薬品3PL 市場規模：用途別
    • 中国のバイオ医薬品3PL 市場規模：用途別 (2018-2023)
    • 中国のバイオ医薬品3PL 市場規模：用途別 (2024-2029)
    • 中国のバイオ医薬品3PLの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 バイオ医薬品3PL 市場規模 (2018-2029)
  • アジア地域 バイオ医薬品3PL 市場規模：タイプ別
    • アジア地域 バイオ医薬品3PL 市場規模：タイプ別 (2018-2023)
    • アジア地域 バイオ医薬品3PL 市場規模：タイプ別 (2024-2029)
    • アジア地域 バイオ医薬品3PLの市場シェア：タイプ別 (2018-2029)
  • アジア地域 バイオ医薬品3PL 市場規模：用途別
    • アジア地域 バイオ医薬品3PL 市場規模：用途別 (2018-2023)
    • アジア地域 バイオ医薬品3PL 市場規模：用途別 (2024-2029)
    • アジア地域 バイオ医薬品3PLの市場シェア：用途別 (2018-2029)
  • アジア地域 バイオ医薬品3PL 市場規模：地域別
    • アジア地域 バイオ医薬品3PL 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 バイオ医薬品3PL 市場規模：地域別 (2018-2023)
    • アジア地域 バイオ医薬品3PL 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：タイプ別
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 バイオ医薬品3PLの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：用途別
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 バイオ医薬品3PLの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：国別
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 バイオ医薬品3PL 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • FedEx.
  • DHL International GmbH
  • SF Express
  • United Parcel Service of America, Inc.
  • AmerisourceBergen Corporation
  • DB Schenker
  • KUEHNE + NAGEL
  • Kerry Logistics Network Limited
  • Agility
  • EMS
  • SF Express
  • Jd.Com, Inc.

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Biopharmaceutical 3PL Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Cold Chain
  • Table 3. Key Players of Non-cold Chain
  • Table 4. Global Biopharmaceutical 3PL Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 5. Global Biopharmaceutical 3PL Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Biopharmaceutical 3PL Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Biopharmaceutical 3PL Market Share by Region (2018-2023)
  • Table 8. Global Biopharmaceutical 3PL Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Biopharmaceutical 3PL Market Share by Region (2024-2029)
  • Table 10. Biopharmaceutical 3PL Market Trends
  • Table 11. Biopharmaceutical 3PL Market Drivers
  • Table 12. Biopharmaceutical 3PL Market Challenges
  • Table 13. Biopharmaceutical 3PL Market Restraints
  • Table 14. Global Biopharmaceutical 3PL Revenue by Players (2018-2023) & (US$ Million)
  • Table 15. Global Biopharmaceutical 3PL Revenue Share by Players (2018-2023)
  • Table 16. Global Top Biopharmaceutical 3PL by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical 3PL as of 2022)
  • Table 17. Global Biopharmaceutical 3PL Industry Ranking 2021 VS 2022 VS 2023
  • Table 18. Global 5 Largest Players Market Share by Biopharmaceutical 3PL Revenue (CR5 and HHI) & (2018-2023)
  • Table 19. Global Key Players of Biopharmaceutical 3PL, Headquarters and Area Served
  • Table 20. Global Key Players of Biopharmaceutical 3PL, Product and Application
  • Table 21. Global Key Players of Biopharmaceutical 3PL, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 24. Global Biopharmaceutical 3PL Revenue Market Share by Type (2018-2023)
  • Table 25. Global Biopharmaceutical 3PL Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 26. Global Biopharmaceutical 3PL Revenue Market Share by Type (2024-2029)
  • Table 27. Global Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 28. Global Biopharmaceutical 3PL Revenue Share by Application (2018-2023)
  • Table 29. Global Biopharmaceutical 3PL Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. Global Biopharmaceutical 3PL Revenue Share by Application (2024-2029)
  • Table 31. North America Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 32. North America Biopharmaceutical 3PL Market Size by Type (2024-2029) & (US$ Million)
  • Table 33. North America Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 34. North America Biopharmaceutical 3PL Market Size by Application (2024-2029) & (US$ Million)
  • Table 35. North America Biopharmaceutical 3PL Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 36. North America Biopharmaceutical 3PL Market Size by Country (2018-2023) & (US$ Million)
  • Table 37. North America Biopharmaceutical 3PL Market Size by Country (2024-2029) & (US$ Million)
  • Table 38. Europe Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 39. Europe Biopharmaceutical 3PL Market Size by Type (2024-2029) & (US$ Million)
  • Table 40. Europe Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 41. Europe Biopharmaceutical 3PL Market Size by Application (2024-2029) & (US$ Million)
  • Table 42. Europe Biopharmaceutical 3PL Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 43. Europe Biopharmaceutical 3PL Market Size by Country (2018-2023) & (US$ Million)
  • Table 44. Europe Biopharmaceutical 3PL Market Size by Country (2024-2029) & (US$ Million)
  • Table 45. China Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 46. China Biopharmaceutical 3PL Market Size by Type (2024-2029) & (US$ Million)
  • Table 47. China Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 48. China Biopharmaceutical 3PL Market Size by Application (2024-2029) & (US$ Million)
  • Table 49. Asia Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 50. Asia Biopharmaceutical 3PL Market Size by Type (2024-2029) & (US$ Million)
  • Table 51. Asia Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 52. Asia Biopharmaceutical 3PL Market Size by Application (2024-2029) & (US$ Million)
  • Table 53. Asia Biopharmaceutical 3PL Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 54. Asia Biopharmaceutical 3PL Market Size by Region (2018-2023) & (US$ Million)
  • Table 55. Asia Biopharmaceutical 3PL Market Size by Region (2024-2029) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Type (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Type (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Application (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Application (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Biopharmaceutical 3PL Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 61. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country (2024-2029) & (US$ Million)
  • Table 63. FedEx. Company Details
  • Table 64. FedEx. Business Overview
  • Table 65. FedEx. Biopharmaceutical 3PL Product
  • Table 66. FedEx. Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 67. FedEx. Recent Developments
  • Table 68. DHL International GmbH Company Details
  • Table 69. DHL International GmbH Business Overview
  • Table 70. DHL International GmbH Biopharmaceutical 3PL Product
  • Table 71. DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 72. DHL International GmbH Recent Developments
  • Table 73. SF Express Company Details
  • Table 74. SF Express Business Overview
  • Table 75. SF Express Biopharmaceutical 3PL Product
  • Table 76. SF Express Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 77. SF Express Recent Developments
  • Table 78. United Parcel Service of America, Inc. Company Details
  • Table 79. United Parcel Service of America, Inc. Business Overview
  • Table 80. United Parcel Service of America, Inc. Biopharmaceutical 3PL Product
  • Table 81. United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 82. United Parcel Service of America, Inc. Recent Developments
  • Table 83. AmerisourceBergen Corporation Company Details
  • Table 84. AmerisourceBergen Corporation Business Overview
  • Table 85. AmerisourceBergen Corporation Biopharmaceutical 3PL Product
  • Table 86. AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 87. AmerisourceBergen Corporation Recent Developments
  • Table 88. DB Schenker Company Details
  • Table 89. DB Schenker Business Overview
  • Table 90. DB Schenker Biopharmaceutical 3PL Product
  • Table 91. DB Schenker Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 92. DB Schenker Recent Developments
  • Table 93. KUEHNE + NAGEL Company Details
  • Table 94. KUEHNE + NAGEL Business Overview
  • Table 95. KUEHNE + NAGEL Biopharmaceutical 3PL Product
  • Table 96. KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 97. KUEHNE + NAGEL Recent Developments
  • Table 98. Kerry Logistics Network Limited Company Details
  • Table 99. Kerry Logistics Network Limited Business Overview
  • Table 100. Kerry Logistics Network Limited Biopharmaceutical 3PL Product
  • Table 101. Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 102. Kerry Logistics Network Limited Recent Developments
  • Table 103. Agility Company Details
  • Table 104. Agility Business Overview
  • Table 105. Agility Biopharmaceutical 3PL Product
  • Table 106. Agility Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 107. Agility Recent Developments
  • Table 108. EMS Company Details
  • Table 109. EMS Business Overview
  • Table 110. EMS Biopharmaceutical 3PL Product
  • Table 111. EMS Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 112. EMS Recent Developments
  • Table 113. SF Express Company Details
  • Table 114. SF Express Business Overview
  • Table 115. SF Express Biopharmaceutical 3PL Product
  • Table 116. SF Express Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 117. SF Express Recent Developments
  • Table 118. Jd.Com, Inc. Company Details
  • Table 119. Jd.Com, Inc. Business Overview
  • Table 120. Jd.Com, Inc. Biopharmaceutical 3PL Product
  • Table 121. Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2018-2023) & (US$ Million)
  • Table 122. Jd.Com, Inc. Recent Developments
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Biopharmaceutical 3PL Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Biopharmaceutical 3PL Market Share by Type: 2022 VS 2029
  • Figure 3. Cold Chain Features
  • Figure 4. Non-cold Chain Features
  • Figure 5. Global Biopharmaceutical 3PL Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 6. Global Biopharmaceutical 3PL Market Share by Application: 2022 VS 2029
  • Figure 7. Transportation Case Studies
  • Figure 8. Warehousing and Storage Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Biopharmaceutical 3PL Report Years Considered
  • Figure 11. Global Biopharmaceutical 3PL Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 12. Global Biopharmaceutical 3PL Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Biopharmaceutical 3PL Market Share by Region: 2022 VS 2029
  • Figure 14. Global Biopharmaceutical 3PL Market Share by Players in 2022
  • Figure 15. Global Top Biopharmaceutical 3PL Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical 3PL as of 2022)
  • Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical 3PL Revenue in 2022
  • Figure 17. North America Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 18. North America Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • Figure 19. North America Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • Figure 20. North America Biopharmaceutical 3PL Market Share by Country (2018-2029)
  • Figure 21. United States Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. Canada Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Europe Biopharmaceutical 3PL Market Size YoY (2018-2029) & (US$ Million)
  • Figure 24. Europe Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • Figure 25. Europe Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • Figure 26. Europe Biopharmaceutical 3PL Market Share by Country (2018-2029)
  • Figure 27. Germany Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. France Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. U.K. Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Italy Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Russia Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Nordic Countries Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. China Biopharmaceutical 3PL Market Size YoY (2018-2029) & (US$ Million)
  • Figure 34. China Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • Figure 35. China Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • Figure 36. Asia Biopharmaceutical 3PL Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. Asia Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • Figure 38. Asia Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • Figure 39. Asia Biopharmaceutical 3PL Market Share by Region (2018-2029)
  • Figure 40. Japan Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. South Korea Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. China Taiwan Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. Southeast Asia Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. India Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Australia Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size YoY (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • Figure 48. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Share by Country (2018-2029)
  • Figure 50. Brazil Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Mexico Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Turkey Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Saudi Arabia Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Israel Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. GCC Countries Biopharmaceutical 3PL Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. FedEx. Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 57. DHL International GmbH Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 58. SF Express Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 59. United Parcel Service of America, Inc. Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 60. AmerisourceBergen Corporation Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 61. DB Schenker Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 62. KUEHNE + NAGEL Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 63. Kerry Logistics Network Limited Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 64. Agility Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 65. EMS Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 66. SF Express Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 67. Jd.Com, Inc. Revenue Growth Rate in Biopharmaceutical 3PL Business (2018-2023)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
目次

This research report focuses on the Biopharmaceutical 3PL Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Cold Chain
    • 1.2.3 Non-cold Chain
  • 1.3 Market by Application
    • 1.3.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Transportation
    • 1.3.3 Warehousing and Storage
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharmaceutical 3PL Market Perspective (2018-2029)
  • 2.2 Global Biopharmaceutical 3PL Growth Trends by Region
    • 2.2.1 Biopharmaceutical 3PL Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Biopharmaceutical 3PL Historic Market Size by Region (2018-2023)
    • 2.2.3 Biopharmaceutical 3PL Forecasted Market Size by Region (2024-2029)
  • 2.3 Biopharmaceutical 3PL Market Dynamics
    • 2.3.1 Biopharmaceutical 3PL Industry Trends
    • 2.3.2 Biopharmaceutical 3PL Market Drivers
    • 2.3.3 Biopharmaceutical 3PL Market Challenges
    • 2.3.4 Biopharmaceutical 3PL Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Biopharmaceutical 3PL by Players
    • 3.1.1 Global Biopharmaceutical 3PL Revenue by Players (2018-2023)
    • 3.1.2 Global Biopharmaceutical 3PL Revenue Market Share by Players (2018-2023)
  • 3.2 Global Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Biopharmaceutical 3PL, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Biopharmaceutical 3PL Market Concentration Ratio
    • 3.4.1 Global Biopharmaceutical 3PL Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical 3PL Revenue in 2022
  • 3.5 Global Key Players of Biopharmaceutical 3PL Head office and Area Served
  • 3.6 Global Key Players of Biopharmaceutical 3PL, Product and Application
  • 3.7 Global Key Players of Biopharmaceutical 3PL, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical 3PL Breakdown Data by Type

  • 4.1 Global Biopharmaceutical 3PL Historic Market Size by Type (2018-2023)
  • 4.2 Global Biopharmaceutical 3PL Forecasted Market Size by Type (2024-2029)

5 Biopharmaceutical 3PL Breakdown Data by Application

  • 5.1 Global Biopharmaceutical 3PL Historic Market Size by Application (2018-2023)
  • 5.2 Global Biopharmaceutical 3PL Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Biopharmaceutical 3PL Market Size (2018-2029)
  • 6.2 North America Biopharmaceutical 3PL Market Size by Type
    • 6.2.1 North America Biopharmaceutical 3PL Market Size by Type (2018-2023)
    • 6.2.2 North America Biopharmaceutical 3PL Market Size by Type (2024-2029)
    • 6.2.3 North America Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • 6.3 North America Biopharmaceutical 3PL Market Size by Application
    • 6.3.1 North America Biopharmaceutical 3PL Market Size by Application (2018-2023)
    • 6.3.2 North America Biopharmaceutical 3PL Market Size by Application (2024-2029)
    • 6.3.3 North America Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • 6.4 North America Biopharmaceutical 3PL Market Size by Country
    • 6.4.1 North America Biopharmaceutical 3PL Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Biopharmaceutical 3PL Market Size by Country (2018-2023)
    • 6.4.3 North America Biopharmaceutical 3PL Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Biopharmaceutical 3PL Market Size (2018-2029)
  • 7.2 Europe Biopharmaceutical 3PL Market Size by Type
    • 7.2.1 Europe Biopharmaceutical 3PL Market Size by Type (2018-2023)
    • 7.2.2 Europe Biopharmaceutical 3PL Market Size by Type (2024-2029)
    • 7.2.3 Europe Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • 7.3 Europe Biopharmaceutical 3PL Market Size by Application
    • 7.3.1 Europe Biopharmaceutical 3PL Market Size by Application (2018-2023)
    • 7.3.2 Europe Biopharmaceutical 3PL Market Size by Application (2024-2029)
    • 7.3.3 Europe Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • 7.4 Europe Biopharmaceutical 3PL Market Size by Country
    • 7.4.1 Europe Biopharmaceutical 3PL Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Biopharmaceutical 3PL Market Size by Country (2018-2023)
    • 7.4.3 Europe Biopharmaceutical 3PL Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Biopharmaceutical 3PL Market Size (2018-2029)
  • 8.2 China Biopharmaceutical 3PL Market Size by Type
    • 8.2.1 China Biopharmaceutical 3PL Market Size by Type (2018-2023)
    • 8.2.2 China Biopharmaceutical 3PL Market Size by Type (2024-2029)
    • 8.2.3 China Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • 8.3 China Biopharmaceutical 3PL Market Size by Application
    • 8.3.1 China Biopharmaceutical 3PL Market Size by Application (2018-2023)
    • 8.3.2 China Biopharmaceutical 3PL Market Size by Application (2024-2029)
    • 8.3.3 China Biopharmaceutical 3PL Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Biopharmaceutical 3PL Market Size (2018-2029)
  • 9.2 Asia Biopharmaceutical 3PL Market Size by Type
    • 9.2.1 Asia Biopharmaceutical 3PL Market Size by Type (2018-2023)
    • 9.2.2 Asia Biopharmaceutical 3PL Market Size by Type (2024-2029)
    • 9.2.3 Asia Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • 9.3 Asia Biopharmaceutical 3PL Market Size by Application
    • 9.3.1 Asia Biopharmaceutical 3PL Market Size by Application (2018-2023)
    • 9.3.2 Asia Biopharmaceutical 3PL Market Size by Application (2024-2029)
    • 9.3.3 Asia Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • 9.4 Asia Biopharmaceutical 3PL Market Size by Region
    • 9.4.1 Asia Biopharmaceutical 3PL Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Biopharmaceutical 3PL Market Size by Region (2018-2023)
    • 9.4.3 Asia Biopharmaceutical 3PL Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Biopharmaceutical 3PL Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 FedEx.
    • 11.1.1 FedEx. Company Details
    • 11.1.2 FedEx. Business Overview
    • 11.1.3 FedEx. Biopharmaceutical 3PL Introduction
    • 11.1.4 FedEx. Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.1.5 FedEx. Recent Developments
  • 11.2 DHL International GmbH
    • 11.2.1 DHL International GmbH Company Details
    • 11.2.2 DHL International GmbH Business Overview
    • 11.2.3 DHL International GmbH Biopharmaceutical 3PL Introduction
    • 11.2.4 DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.2.5 DHL International GmbH Recent Developments
  • 11.3 SF Express
    • 11.3.1 SF Express Company Details
    • 11.3.2 SF Express Business Overview
    • 11.3.3 SF Express Biopharmaceutical 3PL Introduction
    • 11.3.4 SF Express Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.3.5 SF Express Recent Developments
  • 11.4 United Parcel Service of America, Inc.
    • 11.4.1 United Parcel Service of America, Inc. Company Details
    • 11.4.2 United Parcel Service of America, Inc. Business Overview
    • 11.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Introduction
    • 11.4.4 United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.4.5 United Parcel Service of America, Inc. Recent Developments
  • 11.5 AmerisourceBergen Corporation
    • 11.5.1 AmerisourceBergen Corporation Company Details
    • 11.5.2 AmerisourceBergen Corporation Business Overview
    • 11.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Introduction
    • 11.5.4 AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.5.5 AmerisourceBergen Corporation Recent Developments
  • 11.6 DB Schenker
    • 11.6.1 DB Schenker Company Details
    • 11.6.2 DB Schenker Business Overview
    • 11.6.3 DB Schenker Biopharmaceutical 3PL Introduction
    • 11.6.4 DB Schenker Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.6.5 DB Schenker Recent Developments
  • 11.7 KUEHNE + NAGEL
    • 11.7.1 KUEHNE + NAGEL Company Details
    • 11.7.2 KUEHNE + NAGEL Business Overview
    • 11.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Introduction
    • 11.7.4 KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.7.5 KUEHNE + NAGEL Recent Developments
  • 11.8 Kerry Logistics Network Limited
    • 11.8.1 Kerry Logistics Network Limited Company Details
    • 11.8.2 Kerry Logistics Network Limited Business Overview
    • 11.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Introduction
    • 11.8.4 Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.8.5 Kerry Logistics Network Limited Recent Developments
  • 11.9 Agility
    • 11.9.1 Agility Company Details
    • 11.9.2 Agility Business Overview
    • 11.9.3 Agility Biopharmaceutical 3PL Introduction
    • 11.9.4 Agility Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.9.5 Agility Recent Developments
  • 11.10 EMS
    • 11.10.1 EMS Company Details
    • 11.10.2 EMS Business Overview
    • 11.10.3 EMS Biopharmaceutical 3PL Introduction
    • 11.10.4 EMS Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.10.5 EMS Recent Developments
  • 11.11 SF Express
    • 11.11.1 SF Express Company Details
    • 11.11.2 SF Express Business Overview
    • 11.11.3 SF Express Biopharmaceutical 3PL Introduction
    • 11.11.4 SF Express Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.11.5 SF Express Recent Developments
  • 11.12 Jd.Com, Inc.
    • 11.12.1 Jd.Com, Inc. Company Details
    • 11.12.2 Jd.Com, Inc. Business Overview
    • 11.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Introduction
    • 11.12.4 Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2018-2023)
    • 11.12.5 Jd.Com, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details